Foto dell'editore

Imaging in CNS Drug Discovery and Development

David Borsook

0 valutazioni da GoodReads
ISBN 10: 1441901337 / ISBN 13: 9781441901330
Editore: Springer-Verlag Gmbh Dez 2010, 2010
Nuovi Condizione: Neu Buch
Da Rhein-Team Lörrach Ivano Narducci e.K. (Lörrach, Germania)

Libreria AbeBooks dal 11 gennaio 2012

Valutazione Libreria 5 stelle

Quantità: 1

Offerto da altre Librerie

Mostra tutte le  copie di questo libro
Compra nuovo
Prezzo consigliato:
Prezzo: EUR 245,03 Convertire valuta
Spedizione: EUR 12,00 Da: Germania a: U.S.A. Destinazione, tempi e costi
Aggiungere al carrello

Metodi di pagamento
accettati dalla libreria

Visa Mastercard American Express Carte Bleue

Assegno PayPal

Riguardo questo articolo

Neuware - Drug development today needs to balance agility, speed, and risk in defining probability of success for molecules, mechanisms, and therapeutic concepts. New techniques such as fMRI promise to be part of a sequence that could transform drug development. Although numerous review articles exist that discuss the use of imaging in drug development, no one source is available that combines the various techniques and includes a discussion of disease mapping. Imaging in CNS Drug Discovery and Development, Implications for Disease and Therapy will serve to distill the most salient developments in the use of imaging in drug development and disease mapping. It will launch evolving concepts that integrate new imaging technologies and paradigms with molecular medicine and molecular profiling ('monics') as well as consider the ethical issues that arise as a result of disease or state diagnosis and the use of imaging in the public eye. 322 pp. Englisch. Codice inventario libreria 9781441901330

Fare una domanda alla libreria

Dati bibliografici

Titolo: Imaging in CNS Drug Discovery and ...

Casa editrice: Springer-Verlag Gmbh Dez 2010

Data di pubblicazione: 2010

Legatura: Buch

Condizione libro:Neu

Descrizione articolo

Riassunto:

Drug development today needs to balance agility, speed, and risk in defining probability of success for molecules, mechanisms, and therapeutic concepts. New techniques such as fMRI promise to be part of a sequence that could transform drug development. Although numerous review articles exist that discuss the use of imaging in drug development, no one source is available that combines the various techniques and includes a discussion of disease mapping.Imaging in CNS Drug Discovery and Development, Implications for Disease and Therapy will serve to distill the most salient developments in the use of imaging in drug development and disease mapping. It will launch evolving concepts that integrate new imaging technologies and paradigms with molecular medicine and molecular profiling ("monics") as well as consider the ethical issues that arise as a result of disease or state diagnosis and the use of imaging in the public eye.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.